Train Babcock Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Train Babcock Advisors's PFE Position: Q4 2017 in Review
Train Babcock Advisors reduced its Pfizer (PFE) stake by 27% in Q4 2017, selling an estimated $120K and leaving 9,566 shares worth $328K. The position accounts for 0.14% of the portfolio, ranked #79.
Train Babcock Advisors first reported a position in PFE in Q2 2013 and has held it in 19 quarters since. The position peaked at $704K in Q1 2014. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.
- Train Babcock Advisors held 9,566 shares of Pfizer worth $328K as of Q4 2017.
- Train Babcock Advisors sold 3,514 Pfizer shares in Q4 2017, an estimated $120K.
- Pfizer made up 0.14% of Train Babcock Advisors's portfolio in Q4 2017, its #79 holding.
- Train Babcock Advisors first reported a position in Pfizer in Q2 2013 and has held it in 19 quarters since.
- Train Babcock Advisors's Pfizer position peaked at $704K in Q1 2014.
- 2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.
Based on Train Babcock Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.